FDA Clears Guidance System for Computed Tomography

Food and Drug Administration (FDA). The system is designed for use in clinical interventions on anatomic structures where CT is currently employed.

With the new system, called CT-Guide, clinicians can place a biopsy or aspiration needle in a target organ more efficiently and more accurately. Both the needle and the organ are visualized on the CT-Guide display in real-time. Through its Respiratory Gating feature, the CT-Guide compensates for respiratory motion, reducing the margin for error previously attributed to a patient's breathing. The guide attaches to most commercially available CT scanners and can be easily upgraded to meet future technology requirements.

The three main advantages of the CT-Guide are that it is faster, it reduces radiation exposure, and it readily accommodates out-of-plane, complex needle placements, says Andrew Fisher, M.D., a physician at the Swedish Medical Center in Denver (CO, USA).

The CT-Guide was developed by UltraGuide, Inc. (Denver, CO, USA; ), a subsidiary of Israel-based medical device company that develops electronic guidance systems for medical applications.



Related Links:
UltraGuide, Inc.